MedTrace Logo

Evaluation of the Role of Propionibacterium Acnes in the Inflammatory Lesions Associated With Acne Vulgaris

NCT01929057 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2019-10-03

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the response of acne patients and healthy control patients to the P. acnes bacteria. Half a tube of blood will be drawn from all participants to determine whether or not they have antibodies to the P. acnes bacterium. Anywhere from 1 to 4 skin biopsies of acne pimples or normal control skin will be taken from all subjects for further analysis in the lab to determine whether the inflammation in these pimples can be reduced using anti-P.acnes antibodies.

Conditions

Interventions

PROCEDURE

Skin biopsy

4-millimeter punch biopsies will be performed on all subjects (acne patients and healthy controls)

PROCEDURE

Blood draw

Approximately half a tube of blood will be drawn from all participants in the study

Sponsors & Collaborators

Principal Investigators

  • Tissa Hata, MD · UCSD

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01929057 on ClinicalTrials.gov